Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05973643 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metabolomics During ElectroConvulsivoTherapy

Study acronym: METECT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 24, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Re-verified, no change to tracked fieldsv4
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 30, 2024 to Mar 11, 2024
    • Site details revised
    v3
  3. Notable Primary completion date: Oct 15, 2023 to Oct 15, 2025
    • Start date: Oct 15, 2023 to Apr 30, 2024
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,055 trials monitored
See 173 trials at risk
Investigators will measure the variation of blood Metabolome through 1H NMR at several time points during the course of electroconvulsivetherapy in patients with a major depressive episode. Patients with a major depressive disorder or a bipolar disorder and a current major depressive episode will be included in this study. Investigators hypothesized that Metabolome could be a source to predict response during ECT and to help understanding underlying biological mechanisms.
Trial Details
NCT Number NCT05973643
Lead Sponsor Hôpital le Vinatier
Conditions
(from sponsor)
Major Depressive Episode, ECT
Related terms Major Depressive Disorder
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov